We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

127 hedge funds and large institutions have $210M invested in Dynavax Technologies in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $3.4M | Put options by funds: $1.75M

3% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 36

2.41% less ownership

Funds ownership: 83.35%80.93% (-2.4%)

7% less funds holding

Funds holding: 137127 (-10)

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

46% less capital invested

Capital invested by funds: $392M → $210M (-$182M)

Holders
127
Holders Change
-10
Holders Change %
-7.3%
% of All Funds
2.76%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
37
Reduced
36
Closed
30
Calls
$3.4M
Puts
$1.75M
Net Calls
+$1.65M
Net Calls Change
+$823K
Name Holding Trade Value Shares
Change
Change in
Stake
O
26
OrbiMed
New York
$2.33M +$3.38M +583,500 New
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$2.21M +$3.22M +555,000 New
DekaBank Deutsche Girozentrale
28
DekaBank Deutsche Girozentrale
Germany
$2.05M +$754K +130,000 +32%
Morgan Stanley
29
Morgan Stanley
New York
$1.89M +$2.06M +354,760 +298%
Deutsche Bank
30
Deutsche Bank
Germany
$1.69M +$899K +155,034 +58%
Charles Schwab
31
Charles Schwab
California
$1.35M -$28K -4,826 -1%
Axa
32
Axa
France
$1.2M +$1.74M +300,500 New
Goldman Sachs
33
Goldman Sachs
New York
$1.08M -$371K -63,999 -19%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.06M -$66.9K -11,531 -4%
N
35
Nuveen
North Carolina
$969K +$1.41M +242,884 New
Bank of America
36
Bank of America
North Carolina
$819K -$739K -127,410 -38%
Renaissance Technologies
37
Renaissance Technologies
New York
$747K +$1.09M +187,251 New
QIM
38
Quantitative Investment Management
Virginia
$574K +$834K +143,931 New
RA
39
Royce & Associates
New York
$533K -$495K -85,400 -39%
Citigroup
40
Citigroup
New York
$527K +$500K +86,265 +188%
AllianceBernstein
41
AllianceBernstein
Tennessee
$499K +$277K +47,700 +62%
Swiss National Bank
42
Swiss National Bank
Switzerland
$475K +$27.8K +4,800 +4%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$437K +$363K +62,642 +134%
HP
44
Hikari Power
Japan
$421K
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$398K +$25K +4,313 +5%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$355K +$11.6K +2,000 +2%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$343K +$17.2K +2,963 +4%
Wells Fargo
48
Wells Fargo
California
$303K -$48K -8,286 -10%
Walleye Capital
49
Walleye Capital
New York
$303K +$441K +76,000 New
BBA
50
Baker Bros. Advisors
New York
$299K

DVAX Hedge Fund Activity: Q2 2019 in Review

127 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2019, worth a combined $210M — down 46% from $392M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of DVAX and 22 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 37 added.

The largest buyer was Bain Capital Public Equity Management II, opening a new position worth an estimated $7.57M. The largest seller was State Street, cutting an estimated $13.7M.

  • 127 institutional investors held Dynavax Technologies (DVAX) as of Q2 2019, down from 137 in Q1 2019.
  • Funds reported $210M of Dynavax Technologies stock for Q2 2019, down 46% quarter-over-quarter.
  • 22 funds opened new Dynavax Technologies positions in Q2 2019 and 30 closed out, a net change of -8 holders.
  • The largest Dynavax Technologies buyer in Q2 2019 was Bain Capital Public Equity Management II, an estimated $7.57M added.
  • The largest Dynavax Technologies seller in Q2 2019 was State Street, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2019.